Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 27.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 22.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers |
| 01.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 04.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
Stammdaten
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.
Unternehmen & Branche
| Name | Tenon Medical, Inc. |
|---|---|
| Ticker | TNON |
| CIK | 0001560293 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 5,7 Mio. USD |
| Beta | 1,25 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 3,944,000 | -12,556,000 | -1.70 | 10,760,000 | 5,040,000 |
| 2025-09-30 | 10-Q | 1,173,000 | -3,339,000 | -0.40 | 10,366,000 | 4,798,000 |
| 2025-06-30 | 10-Q | 564,000 | -2,769,000 | -0.36 | 11,114,000 | 6,713,000 |
| 2025-03-31 | 10-Q | 726,000 | -3,616,000 | -1.01 | 13,394,000 | 9,376,000 |
| 2024-12-31 | 10-K | 3,277,000 | -13,673,000 | -11.26 | 9,843,000 | 5,971,000 |
| 2024-09-30 | 10-Q | 887,000 | -3,184,000 | -3.63 | 13,039,000 | 8,191,000 |
| 2024-06-30 | 10-Q | 901,000 | -3,826,000 | -8.16 | 6,006,000 | 832,000 |
| 2024-03-31 | 10-Q | 719,000 | -3,576,000 | -10.02 | 8,020,000 | 3,624,000 |
| 2023-12-31 | 10-K | 2,928,000 | -15,581,000 | -68.64 | 6,345,000 | 778,000 |
| 2023-09-30 | 10-Q | 944,000 | -3,332,000 | -11.69 | 7,318,000 | 2,517,000 |
| 2023-06-30 | 10-Q | 743,000 | -4,285,000 | -3.28 | 9,855,000 | 903,000 |
| 2023-03-31 | 10-Q | 433,000 | -4,830,000 | -4.30 | 7,629,000 | 2,474,000 |
| 2022-12-31 | 10-K | 691,000 | -18,917,000 | -23.62 | 11,089,000 | 6,252,000 |
| 2022-09-30 | 10-Q | 208,000 | -3,171,000 | -2.82 | 14,937,000 | 12,947,000 |
| 2022-06-30 | 10-Q | 135,000 | -5,488,000 | -0.65 | 18,131,000 | 15,113,000 |
| 2022-03-31 | 10-Q | 71,000 | -2,353,000 | -2.38 | 7,145,000 | -22,736,000 |
| 2021-12-31 | 10-K | 160,000 | -7,048,000 | -7.81 | 9,272,000 | -20,552,000 |
| 2021-09-30 | 10-Q | 70,000 | -2,341,000 | -2.55 | -5,923,000 | |
| 2021-06-30 | 10-Q | 22,000 | -1,665,000 | -2.01 | -4,140,000 | |
| 2021-03-31 | 10-Q | 15,000 | -200,000 | -2,906,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | FOSTER STEVEN M | Director, Officer, CEO and President | Open Market Purchase | 19,455 | 0.00 | 0.00 | 0,0% | |
| 2025-11-14 | Geist Wyatt D. | Officer, Chief Innovation Officer | Open Market Purchase | 19,455 | 0.00 | 0.00 | 0,0% | |
| 2025-11-14 | Grawey Nathaniel A. | Officer, Chief Commercial Officer | Open Market Purchase | 101,167 | 0.00 | 0.00 | 0,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.